Sara Martire

1.4k total citations · 1 hit paper
19 papers, 894 citations indexed

About

Sara Martire is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Sara Martire has authored 19 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 2 papers in Neurology. Recurrent topics in Sara Martire's work include PARP inhibition in cancer therapy (6 papers), CAR-T cell therapy research (4 papers) and Epigenetics and DNA Methylation (4 papers). Sara Martire is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), CAR-T cell therapy research (4 papers) and Epigenetics and DNA Methylation (4 papers). Sara Martire collaborates with scholars based in United States, Italy and South Africa. Sara Martire's co-authors include Laura A. Banaszynski, Maria D’Erme, Luciana Mosca, Aishwarya Sundaresan, Bruno Maras, Cesare Giordano, Andrea Fuso, Sigfrido Scarpa, Antonio Francioso and Jennifer Nguyen and has published in prestigious journals such as Nature Communications, Nature Reviews Molecular Cell Biology and PLoS ONE.

In The Last Decade

Sara Martire

17 papers receiving 887 citations

Hit Papers

The roles of histone variants in fine-tuning chromatin or... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Martire United States 12 541 220 155 77 67 19 894
Song Shi China 18 634 1.2× 174 0.8× 207 1.3× 93 1.2× 126 1.9× 28 1.0k
Ava Safaroghli‐Azar Iran 20 578 1.1× 147 0.7× 137 0.9× 44 0.6× 72 1.1× 45 969
Zhihua Yang China 22 707 1.3× 145 0.7× 204 1.3× 118 1.5× 95 1.4× 60 1.2k
Pamela A. Lochhead United Kingdom 18 1.2k 2.2× 174 0.8× 167 1.1× 61 0.8× 49 0.7× 21 1.6k
Kevin R. W. Ngoei Australia 14 762 1.4× 99 0.5× 102 0.7× 63 0.8× 59 0.9× 20 1.0k
Barbara Fischer Germany 19 587 1.1× 210 1.0× 230 1.5× 154 2.0× 87 1.3× 47 1.2k
Shaosong Yang United States 12 745 1.4× 98 0.4× 105 0.7× 97 1.3× 56 0.8× 13 1.1k
Jongmin Jacob Woo United States 17 465 0.9× 71 0.3× 106 0.7× 57 0.7× 47 0.7× 36 888
Søren Feddersen Denmark 17 404 0.7× 125 0.6× 188 1.2× 22 0.3× 69 1.0× 40 859
Guangyu Gu United States 14 535 1.0× 264 1.2× 97 0.6× 37 0.5× 135 2.0× 22 1.1k

Countries citing papers authored by Sara Martire

Since Specialization
Citations

This map shows the geographic impact of Sara Martire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Martire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Martire more than expected).

Fields of papers citing papers by Sara Martire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Martire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Martire. The network helps show where Sara Martire may publish in the future.

Co-authorship network of co-authors of Sara Martire

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Martire. A scholar is included among the top collaborators of Sara Martire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Martire. Sara Martire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
DiAndreth, Breanna, Aaron Winters, Claudia A. Jette, et al.. (2025). Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy. Frontiers in Immunology. 16. 1493329–1493329. 3 indexed citations
2.
Gafken, Philip R., Sara Martire, Gabriel Boyle, et al.. (2025). The length of the G1 phase is an essential determinant of H3K27me3 landscapes across diverse cell types. PLoS Biology. 23(4). e3003119–e3003119.
3.
Martire, Sara, Michele McElvain, Thomas J. Gill, et al.. (2024). High‐throughput screen to identify and optimize NOT gate receptors for cell therapy. Cytometry Part A. 105(10). 741–751. 1 indexed citations
4.
Wu, Chia-Hua, Brian D. Kelly, Lyndsay E.A. Young, et al.. (2023). PASK links cellular energy metabolism with a mitotic self-renewal network to establish differentiation competence. eLife. 12. 5 indexed citations
6.
Huang, Dan, Cristel V. Camacho, Sara Martire, et al.. (2022). Oncohistone Mutations Occur at Functional Sites of Regulatory ADP-Ribosylation. Cancer Research. 82(13). 2361–2377. 5 indexed citations
7.
Wang, Xueyin, Lu Min Wong, Michele McElvain, et al.. (2022). A rational approach to assess off-target reactivity of a dual-signal integrator for T cell therapy. Toxicology and Applied Pharmacology. 437. 115894–115894. 6 indexed citations
8.
Sandberg, Mark L., Michele McElvain, Sanam Shafaattalab, et al.. (2022). A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo. Science Translational Medicine. 14(634). eabm0306–eabm0306. 41 indexed citations
9.
Teng, Yu‐Ching, Aishwarya Sundaresan, Ryan O’Hara, et al.. (2021). ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. Nature Communications. 12(1). 3887–3887. 64 indexed citations
10.
Martire, Sara & Laura A. Banaszynski. (2020). The roles of histone variants in fine-tuning chromatin organization and function. Nature Reviews Molecular Cell Biology. 21(9). 522–541. 260 indexed citations breakdown →
11.
Martire, Sara, Jennifer Nguyen, Aishwarya Sundaresan, & Laura A. Banaszynski. (2020). Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. BMC Molecular and Cell Biology. 21(1). 55–55. 44 indexed citations
12.
Correani, Virginia, Sara Martire, Giuseppina Mignogna, et al.. (2018). Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cells. Biochemical Pharmacology. 167. 50–57. 15 indexed citations
13.
Giorgi, Alessandra, Italo Tempera, Giorgia Napoletani, et al.. (2017). Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies. Acta Diabetologica. 54(9). 833–842. 14 indexed citations
14.
Cavallaro, Rosaria A., Andrea Fuso, Maria D’Erme, et al.. (2016). Role of S-adenosylmethionine in the Modulation of Oxidative Stress- Related Neurodegeneration. 2(1). 9 indexed citations
15.
Martire, Sara, Andrea Fuso, Luciana Mosca, et al.. (2016). Bioenergetic Impairment in Animal and Cellular Models of Alzheimer’s Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions. Journal of Alzheimer s Disease. 54(1). 307–324. 56 indexed citations
16.
Francioso, Antonio, Pasqualina Punzi, Alberto Boffi, et al.. (2015). β-Sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis. Bioorganic & Medicinal Chemistry. 23(8). 1671–1683. 67 indexed citations
17.
Martire, Sara, Luciana Mosca, & Maria D’Erme. (2015). PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases. Mechanisms of Ageing and Development. 146-148. 53–64. 183 indexed citations
18.
Martire, Sara, Andrea Fuso, Dante Rotili, et al.. (2013). PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage. PLoS ONE. 8(9). e72169–e72169. 71 indexed citations
19.
Cassano, Tommaso, A. Masci, Antonio Francioso, et al.. (2013). 5‐S‐cysteinyldopamine neurotoxicity: Influence on the expression of α‐synuclein and ERp57 in cellular and animal models of Parkinson's disease. Journal of Neuroscience Research. 92(3). 347–358. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026